We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
-$36.6M
Cap. Flow
-$73.8M
Cap. Flow %
-0.42%
Top 10 Hldgs %
30.57%
Holding
716
New
41
Increased
319
Reduced
225
Closed
41

Top Buys

Rank Stock Value
1
WM icon
Waste Management
WM
+$59.7M
2
MSFT icon
Microsoft
MSFT
+$55.1M
3
MA icon
Mastercard
MA
+$53.2M
4
LRCX icon
Lam Research
LRCX
+$52M
5
WMT icon
Walmart Inc
WMT
+$52M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.1M
2
UNH icon
UnitedHealth
UNH
+$65.8M
3
AMGN icon
Amgen
AMGN
+$58M
4
IQV icon
IQVIA
IQV
+$50.8M
5
CSCO icon
Cisco
CSCO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Healthcare 24.06%
3 Financials 11.65%
4 Consumer Discretionary 8.41%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
226
PayPal
PYPL
$50.7B
$12.9M 0.07%
151,458
-10,361
-6% -$871K
LEGN icon
227
Legend Biotech
LEGN
$3.64B
$12.8M 0.07%
393,452
+27,465
+8% +$1.14M
MKC icon
228
McCormick & Company Non-Voting
MKC
$13.9B
$12.8M 0.07%
167,554
+111,789
+200% +$8.78M
T icon
229
AT&T
T
$165B
$12.7M 0.07%
556,249
+34,700
+7% +$781K
WTRG icon
230
Essential Utilities
WTRG
$11.5B
$12.7M 0.07%
348,481
-8,964
-3% -$348K
VLO icon
231
Valero Energy
VLO
$89.6B
$12.6M 0.07%
102,814
+3,264
+3% +$437K
PWR icon
232
Quanta Services
PWR
$83.9B
$12.5M 0.07%
39,609
-37,046
-48% -$11.9M
MLTX icon
233
MoonLake Immunotherapeutics
MLTX
$1.58B
$12.3M 0.07%
227,476
-11,524
-5% -$588K
FERG icon
234
Ferguson
FERG
$43.5B
$12.2M 0.07%
70,102
+5,505
+9% +$1.09M
PLD icon
235
Prologis
PLD
$135B
$12.1M 0.07%
114,596
+15,449
+16% +$1.78M
NRIX icon
236
Nurix Therapeutics
NRIX
$2.45B
$12M 0.07%
634,626
-427,333
-40% -$9.8M
BURL icon
237
Burlington
BURL
$23.5B
$11.9M 0.07%
41,870
+37,978
+976% +$10.3M
TERN
238
DELISTED
Terns Pharmaceuticals
TERN
$11.9M 0.07%
+2,153,969
New +$14.6M
PLRX icon
239
Pliant Therapeutics
PLRX
$65.6M
$11.9M 0.07%
900,104
+66,888
+8% +$913K
IDXX icon
240
Idexx Laboratories
IDXX
$44.9B
$11.8M 0.07%
28,544
+5,610
+24% +$2.46M
DELL icon
241
Dell
DELL
$240B
$11.7M 0.07%
101,812
+1,891
+2% +$237K
PAYC icon
242
Paycom
PAYC
$7.95B
$11.7M 0.07%
56,995
+31,838
+127% +$6.48M
BAP icon
243
Credicorp
BAP
$30.6B
$11.3M 0.07%
+61,900
New +$11.6M
PFE icon
244
Pfizer
PFE
$143B
$11.2M 0.06%
422,501
+30,207
+8% +$819K
ITW icon
245
Illinois Tool Works
ITW
$83.8B
$11.2M 0.06%
43,995
+2,324
+6% +$617K
BIO icon
246
Bio-Rad Laboratories Class A
BIO
$8.77B
$11.1M 0.06%
33,747
+2,220
+7% +$754K
MGA icon
247
Magna International
MGA
$18.9B
$10.9M 0.06%
261,497
-25,658
-9% -$1.1M
BRKR icon
248
Bruker
BRKR
$9.3B
$10.8M 0.06%
184,946
-195,838
-51% -$11.6M
GH icon
249
Guardant Health
GH
$19.3B
$10.8M 0.06%
352,492
-13,653
-4% -$384K
RNAM
250
DELISTED
Avidity Biosciences
RNAM
$10.5M 0.06%
360,710
+37,314
+12% +$1.56M

Similar funds

Candriam SCA's Q4 2024 Portfolio in Review

As of Q4 2024, Candriam SCA held 716 positions worth $17.4B, down 0.21% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q4 2024 filing shows 41 new, 319 increased, 225 reduced and 41 closed positions. Its largest new stake was Lam Research: 685,631 shares worth $49.5M. The largest sale was Alphabet (Google) Class A, an estimated $71.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2024 buy was Lam Research: 685,631 shares worth $49.5M.
  • Candriam SCA added most to Waste Management in Q4 2024, an estimated $59.7M increase.
  • Candriam SCA's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $71.1M.
  • Candriam SCA fully exited Kanzhun in Q4 2024, selling an estimated $22.5M.
  • Candriam SCA's ten largest holdings make up 31% of its $17.4B portfolio in Q4 2024.
  • Candriam SCA opened 41 new positions and closed 41 in Q4 2024.
  • Candriam SCA's portfolio value fell 0.21% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.